Electrotherapy for the Masses: Distribution of
FDA-cleared Electrical Device Offers Hope for Millions
Medical, LLC announces today its distribution of an FDA-cleared
electrical device that effectively treats depression, anxiety, insomnia,
Cincinnati, OH (PRWEB) August 1, 2006 -- Moeller Medical, LLC
announces today its distribution of an FDA-cleared electrical device
that effectively treats depression, anxiety, insomnia, and pain.
Unlike traditional ‘shock therapy,’ this treatment, called Cranial
Electrotherapy Stimulation (CES), delivers a dose of electricity that is
almost undetectable. These "micro-currents" attempt to mimic the body’s
own natural electrical function. In doing so, it is thought that they
stimulate the areas of the brain responsible for neurotransmitter and
hormone production. Most patients report a decrease in symptoms after
just one treatment session. This supports clinical studies that show an
increase in patients' serotonin and beta-endorphin levels immediately
"Patients with treatment-resistant depression have shown significant
elevations in plasma serotonin" said Marshall F. Gilula, M.D. and Paul
R. Barach, M.D. from University of Miami’s School of Medicine.
"Increases in cerebrospinal fluid level of beta-endorphins up to 219%,
plasma endorphins up to 98%, and cerebrospinal fluid serotonin up to
200% have been demonstrated in normal volunteers receiving 20 minutes of
Interestingly, Cranial Electrotherapy Stimulation is actually very safe
compared to most medication. It has almost no side effects and can be
used for any age group. In contrast, most antidepressant and
anti-anxiety medication on the market now carry ‘Black Box Warning’
labels and many are not approved for use in minors.
With new non-drug treatments emerging such as Transcranial Magnetic
Stimulation (TMS) by Neuronetics, Inc. and Vagus Nerve Stimulation (VNS)
by Cyberonics, Inc., Moeller Medical thinks it has found a much needed
niche in this arena. VNS and TMS therapy, while their actions differ
from CES, also provide electrical stimulation of the brain. VNS requires
invasive surgery to implant a device which can be very prohibitive for
some and TMS is not yet accessible to the public. CES is a readily
available, easy to implement treatment for patients.
While its indications are restricted to depression, anxiety, insomnia,
and pain, recent research has shown promising results with disorders
such as fibromyalgia, migraine headaches, and ADHD.
"We have demonstrated that active treatment with CES results in
significant improvement in a number of clinical parameters associated
with fibromyalgia. The results of our investigation appear to be most
encouraging, given the refractory nature of fibromyalgia pain to
conventional pain management," says Randall C. Cork, M.D., Ph.D., from
Louisiana State University’s Health Sciences Center.
"Fibromyalgia affects millions of patients worldwide who are often
resistant to or cannot tolerate medication," said Moeller Medical
President and CEO, Karl Moeller. "It is exciting to be able to work
toward a positive treatment option for this often debilitating
Moeller Medical has launched two informational web sites for patients
and professionals to learn about the device,
Depression Treatment Now and
Anxiety Treatment Now, and plans to follow up with informative sites
later this year for insomnia and pain.
About Moeller Medical, Inc.
Moeller Medical, LLC is a privately held company based in Cincinnati,
OH. Moeller Medical is dedicated to bringing safe, quality healthcare
products to the patient and medical community and is proud to offer a
completely non-invasive drug-free form of psychological and pain
treatment. For more information; visit
# # #